Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Blood Coagul Fibrinolysis. 2020 Jun;31(4):279-282. doi: 10.1097/MBC.0000000000000904.
: We herein report the case of a young patient who presented with premature thromboembolic venous disease secondary to combined heterozygous G20210A prothrombin mutation, dual homozygosity for Factor V Leiden, and severe protein S deficiency. This association has never been reported to date and is likely to be exceptional, even in populations wherein these thrombophilia traits are more common. Long-term antithrombotic prophylaxis with rivaroxaban has proven successful in preventing clinical recurrence under prolonged treatment.
: 我们在此报告一例年轻患者,其因合并杂合子 G20210A 凝血酶原突变、因子 V 莱顿双重纯合子和严重蛋白 S 缺乏导致过早发生血栓栓塞性静脉疾病。这种关联迄今为止从未有报道,即使在这些血栓形成倾向更为常见的人群中,也可能是罕见的。长期应用利伐沙班进行抗血栓预防治疗在延长治疗期间成功预防了临床复发。